What is Polaryx Therapeutics, Inc. 's total liabilities & equity?

Polaryx Therapeutics, Inc. (PLYX) reported total liabilities & equity of $3.5M in Q1 2026.

What does total liabilities & equity mean?

Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.

Polaryx Therapeutics, Inc. PLYX Total Liabilities & Equity

Total Liabilities & Equity at other companies

BioMarin PharmaceuticalsBMRN

$8.59B+20.2%

Zevra Therapeutics, Inc.ZVRA

$278.58M+61.3%

Eton Pharmaceuticals, Inc.ETON

$97.71M+16.3%

XER

Xeris Biopharma Holdings, Inc.XERS

$392.01M+24.3%

Relay Therapeutics, Inc.RLAY

$699.61M-12.5%

PVL

Palvella TherapeuticsPVLA

$263.76M+232%

Other financials

Income statement

See full

Operating income-$2.0M+61.2%

Net income-$2.5M+49.6%

EPS (diluted)-$0.05+54.5%

Balance sheet

See full

Cash & equivalents$3.1M+1,132%

Total equity$2.5M-41.5%

Total assets$3.5M—

Cash flow

See full

Operating cash flow-$2.1M-191%

Valuation

See full

Market cap$132.59M-87.6%

Returns & leverage

See full

Return on equity-1,209.8%—

Current ratio3.5×—

Where this comes from

Reported directly by Polaryx Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The official record: Polaryx Therapeutics, Inc. ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Polaryx Therapeutics, Inc. 's total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Polaryx Therapeutics, Inc. 's total liabilities & equity?: Polaryx Therapeutics, Inc. (PLYX) reported total liabilities & equity of $3.5M in Q1 2026.
What does total liabilities & equity mean?: Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.